[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359564-105":59,"doc-detail-359564-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","epidemiology-and-clinical-features-of-breast-cancer-in-cotonou-2014-2019-insights-from-a-population-based-registry-study","Epidemiology and Clinical Features of Breast Cancer in Cotonou (2014-2019): Insights from a Population-Based Registry Study","","Breast cancer remains the most commonly diagnosed cancer and a leading cause of cancer-related mortality among women, motivating a population-based assessment in Cotonou, Benin. This retrospective cohort study analyzed 277 women registered from 1 January 2014 to 31 December 2019, using descriptive statistics for epidemiological profile, clinical presentation, and survival outcomes. Crude incidence rose from 16.8 per 100,000 in 2014 to 24.7 in 2019, with peak values in 2018. Most cases presented at advanced stages (III–IV), with T4 tumors and triple-negative disease prevailing. Overall survival was 57% at 1 year and 37% at 5 years, underscoring the need for stronger prevention and early detection.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epidemiology-and-clinical-features-of-breast-cancer-in-cotonou-2014-2019-insights-from-a-population-based-registry-study/359564/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epidemiology-and-clinical-features-of-breast-cancer-in-cotonou-2014-2019-insights-from-a-population-based-registry-study/359564.png","ImageObject",300,407,{"name":92,"@type":93},"Sophia Brooks","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study goal in Cotonou, Benin?","Question",{"text":112,"@type":113},"To describe the epidemiological profile and clinical characteristics of breast cancer cases diagnosed from 2014 to 2019 among women residing in Cotonou.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many patients and what registration period were included?",{"text":117,"@type":113},"The study included 277 women registered in the Cotonou Population-Based Cancer Registry between 1 January 2014 and 31 December 2019.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main clinical and molecular findings?",{"text":121,"@type":113},"Most patients were diagnosed at advanced stages (III and IV), T4 tumors were the most frequent presentation, and triple-negative breast cancer was the most prevalent molecular subtype.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359564,1790934285,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Ann Surg Oncol (2026) 33:4427–4435  \n[https://doi.org/10.1245/s10434-025-18976-1](https://doi.org/10.1245/s10434-025-18976-1)  \nORIGINAL ARTICLE – BREAST ONCOLOGY  \nEpidemiology and Clinical Features of Breast Cancer in Cotonou (2014‑2019): Insights from a Population‑Based Registry Study  \nFreddy Houéhanou Rodrigue Gnangnon, Pr1,2,3,4,5,6, Alexis Parenté, Dr1,2,  \nTogueyadji Emmanuel Allayambaye, MsC1, Hélène Robin Sacca, Dr1,2, Salmane Amidou, Dr5,6, Benjamin Dossou‑Yovo, Dr1, Justie Kyria Houlda Mfoutou Mboko, Dr1, Richard Biaou Boni, MsC1, Cosme Toume, Dr5,6, Véronique Blanquet, Pr2, Pierre‑Marie Preux, Pr2, and  \nDismand Stephan Houinato, Pr1,2  \n1Laboratory of Epidemiology of Chronic and Neurological Diseases, LEMACEN, Cotonou, Benin; 2Inserm U1094, IRD U270, Univ. Limoges, CHU Limoges, EpiMaCT-Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France; 3Department of Visceral Surgery, National Teaching Hospital-Hubert Koutoukou Maga, CNHU-HKM, Cotonou, Benin; 4Department of Surgical Oncology, Faculty of Health Sciences, University of Abomey-Calavi, Cotonou, Benin; 5National Non-Communicable Diseases Control Program, Ministry of Health, Cotonou, Republic of Benin; 6Cotonou Cancer Registry/National Program for the Fight Against NCDs/MOH, Cotonou, Benin  \nABSTRACT  \nIntroduction. Breast cancer is the most frequently diagnosed cancer worldwide and a leading cause of cancerrelated mortality in women. This study aimed to describe the epidemiological profile and clinical characteristics of breast cancer cases diagnosed between 2014 and 2019 among women residing in Cotonou, Benin.  \nPatients and Method. This retrospective cohort study included 277 women with breast cancer registered in the Cotonou Population-Based Cancer Registry between 1 January 2014 and 31 December 2019. Qualitative variables were expressed as frequencies and percentages, whereas continuous variables were summarized as means with standard deviations. Overall survival was estimated using the Kaplan–Meier method. Data analyses were performed using R software (version 3.6.1) and SPSS.  \nResults. The crude incidence of breast cancer increased from 16.8 cases per 100,000 population in 2014 to 24.7 in 2019, with a peak of 38.9 in 2018. The mean age at diagnosis was 49.6 ± 11.9 years. Most patients were diagnosed at  \n© The Author(s) 2026  \nFirst Received: 13 May 2025  \nAccepted: 17 December 2025  \nPublished online: 11 January 2026  \nA. Parenté, Dr  \ne-mail: [alexis.parente@unilim.fr](alexis.parente@unilim.fr)  \nadvanced stages (III and IV), with T4 tumors being the most frequent presentation. Triple-negative breast cancer was the most prevalent molecular subtype. Overall survival was 57% at 1 year and 37% at 5 years.  \nConclusions. Breast cancer in Cotonou predominantly affects relatively young women and is often diagnosed at advanced stages, contributing to poor survival outcomes compared with high-income countries. Strengthening early detection and prevention strategies should be a public health priority.  \nKeywords Breast cancer · Epidemiology · Incidence · Cancer registry · Survival · Benin  \nBreast cancer is the leading cancer among women worldwide in both incidence and mortality, with 2,308,897 new cases and more than 665,684 deaths reported in 2022, according to the Global Cancer Observatory (GLOBOCAN 2022) .1  \nThe highest incidence rates are recorded in high-income countries, but 67% of deaths worldwide occur in low-and middle-income countries (LMICs), such as those in subSaharan Africa (SSA) .2 In fact, although women in highincome countries have significantly higher incidence rates than those in low-income countries (54.1 versus 30.8 per  \n100,000), they have significantly lower mortality rates (11.3 versus 15.3 per 100,000) .1  \nIn sub-Saharan Africa, female breast cancer ranks first and was estimated to account for 27.3%(129,400 cases) of the 474,000 female cancer cases in 2020.3 It","cbCaij3yH56QbChb","https://ap.wps.com/l/cbCaij3yH56QbChb","pdf",533681,"English","# Abstract\n# Introduction\n# Patients and Materials\n## Study Population\n# Results\n## Incidence and Clinical Features\n## Survival","[{\"question\":\"What was the study goal in Cotonou, Benin?\",\"answer\":\"To describe the epidemiological profile and clinical characteristics of breast cancer cases diagnosed from 2014 to 2019 among women residing in Cotonou.\"},{\"question\":\"How many patients and what registration period were included?\",\"answer\":\"The study included 277 women registered in the Cotonou Population-Based Cancer Registry between 1 January 2014 and 31 December 2019.\"},{\"question\":\"What were the main clinical and molecular findings?\",\"answer\":\"Most patients were diagnosed at advanced stages (III and IV), T4 tumors were the most frequent presentation, and triple-negative breast cancer was the most prevalent molecular subtype.\"}]","Epidemiology and Clinical Features of Breast Cancer in Cotonou (2014-2019): Insights from a Population-Based Registry Study | PDF",1790137183,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c824959c0cdd1c9893bacbb321b4e133.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a14cde5576cdd90bae67b6aaa94b4433.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0847e69706c66584099a104043a1bdba.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7bdd05f92fab3d2f422464667ce8e1d.webp",980,1301]